X0306 4 2020-10-05 0 0001769804 Augmedix, Inc. NONE 0001826030 Krikorian Jason C/O AUGMEDIX, INC. 1161 MISSION STREET, SUITE 210 SAN FRANCISCO CA 94103 1 0 1 0 Common Stock 2020-10-05 4 A 0 3064751 A 3064751 I See footnote Common Stock 2020-10-05 4 P 0 666667 3.00 A 3731418 I See footnote Common Stock 2020-10-05 4 A 0 20007 A 20007 I See footnote Warrant (right to buy) 2.88 2020-10-05 4 A 0 269490 A 2029-09-02 Common Stock 269490 269490 I See footnote On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer. These securities are held of record by DCM VI, L.P. ("DCM VI"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of DCM VI. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. These securities are held of record by A-Fund, L.P. ("A-Fund"). The Reporting Person, a member of our board of directors, is a general partner at DCM, which is an affiliate of A-Fund. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any. The warrants are fully vested and exerciseable. /s/ Paul Ginocchio, Attorney-in-Fact 2020-10-07